Sunday, November 8, 2026

USD/CNH Is 5% Down In The Last 21 Sessions

USD/CNH Is 5% Down In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 5.79% for the last 21 sessions. At 00:15 EST on Thursday, 23 March, USD/CNH (USDCNH) is $6.83.

USD/CNH's yearly highs and lows, it's 0.053% up from its 52-week low and 0.439% down from its 52-week high.

News about

  • Eur/usd price analysis: pair revisits descending trendline at 1.0720 level before FOMC meeting. According to FXStreet on Tuesday, 21 March, "The three-day bullish rally for EUR/USD has led to a retest of the descending trendline that originates from February's high at the 1.1036 level.", "A convincing break below this point could send EUR/USD down to the multi-month low of 1.0525, the last line of support."
  • Eur/usd forex signal: bullish sentiment if it Zooms past 1.0750 - 21 March 2023. According to DailyForex on Tuesday, 21 March, "The EUR/USD exchange rate bounced back after falling to a low of 1.0522 on March 15. ", "The EUR/USD rose as the US dollar index slumped to $103 and American indices like the Dow Jones and S&P 500 indices jumped by almost 1%. "
  • Eur/usd: A 50 bps increase by the fed and/or upward revision of the dots to smother bullish argument – socgen. According to FXStreet on Tuesday, 21 March, "A smaller 25 bps rate increase or a pause by the FOMC on Wednesday and minor (upward) revision of the dot-plot should, in theory, help EUR/USD to return to the upward trajectory of January.", "A 50 bps increase by the Fed and/or significant upward revision of the dots would be a major surprise and would backfire for risk assets and smother the bullish EUR/USD argument."
  • Eur/usd climbs above 1.0700 on risk-on mood, soft US dollar. According to FXStreet on Tuesday, 21 March, "At the time of writing, the EUR/USD is trading at 1.0774 after hitting a low of 1.0703.", "The EUR/USD continued to rally to a five-week high of 1.0788 but fell shy of testing the 1.0800 mark. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com